UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
SECURITIES EXCHANGE ACT OF 1934
________________________________________
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ | Preliminary Proxy Statement | ||||
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) | ||||
¨ | Definitive Proxy Statement | ||||
x | Definitive Additional Materials | ||||
¨ | Soliciting Material Pursuant to §240.14a‑12 |
Denali Therapeutics Inc.
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check the appropriate box):
x | No fee required | ||||
¨ | Fee paid previously with preliminary materials | ||||
¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a‑6(i)(1) and 0‑11 |
![proxycard1.jpg](https://capedge.com/proxy/DEFA14A/0001714899-22-000069/proxycard1.jpg)
![proxycard2.jpg](https://capedge.com/proxy/DEFA14A/0001714899-22-000069/proxycard2.jpg)